# Nautilus Biotechnology, Inc.: Form 8-K, filed Dec 14, 2023

- Company: [Nautilus Biotechnology, Inc.](/companies/naut.md) (CIK 1808805)
- Form: 8-K
- Filed: 2023-12-14
- Accepted by EDGAR: Dec 14, 2023, 16:17 ET
- Period: 2023-12-14
- Accession: 0001808805-23-000084
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1808805/000180880523000084/naut-20231214.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1808805/000180880523000084/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1808805/000180880523000084/naut-20231214.htm

Filed Dec 14, 2023.
Source: SEC EDGAR, the filing index for accession 0001808805-23-000084. Last ingested by Listed: Nov 3, 2026, 18:40 ET. No prices; not investment advice.
